|
EGLN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.035490E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.628300E-04 |
| Normal-vs-Stage2 |
1.646200E-01 |
| Normal-vs-Stage3 |
3.98449999999828E-05 |
| Normal-vs-Stage4 |
8.2750999999992E-05 |
| Stage1-vs-Stage2 |
7.883700E-02 |
| Stage1-vs-Stage3 |
1.915030E-01 |
| Stage1-vs-Stage4 |
2.428600E-01 |
| Stage2-vs-Stage3 |
1.760370E-02 |
| Stage2-vs-Stage4 |
2.315900E-02 |
| Stage3-vs-Stage4 |
8.871800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63370000000529E-05 |
| Normal-vs-AfricanAmerican |
5.299800E-02 |
| Normal-vs-Asian |
3.386200E-04 |
| Caucasian-vs-AfricanAmerican |
3.099200E-01 |
| Caucasian-vs-Asian |
7.849200E-01 |
| AfricanAmerican-vs-Asian |
2.511600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.659840E-03 |
| Normal-vs-Female |
7.90569999999935E-05 |
| Male-vs-Female |
4.864800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.418700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.013500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.401900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.431700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.099200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.028400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.967200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.229600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.702000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.017800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.565100E-04 |
| Classical-VS-Follicular |
3.322800E-01 |
| Classical-VS-Other |
2.835200E-01 |
| Classical-VS-Normal |
6.637300E-04 |
| Tall-VS-Follicular |
5.430000E-04 |
| Tall-VS-Other |
7.411200E-01 |
| Tall-VS-Normal |
4.74349999946E-07 |
| Follicular-VS-Other |
2.023400E-01 |
| Follicular-VS-Normal |
2.951700E-02 |
| Other-VS-Normal |
1.175730E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.632800E-04 |
| Normal-vs-N1 |
9.49439999953228E-07 |
| N0-vs-N1 |
4.339500E-02 |
|
|
